Also Notable

• ABB Optical Group has announced it has collaborated with EyecareLive, a telemedicine technology, to provide more options for eye care professionals to connect with their patients during the continuing coronavirus (COVID-19) pandemic and beyond. For more information, visit eyecarelive.com/abb .
• Alcon has launched the “No Reason to Wait: Success Starts Now” program to help eye care professionals who do not currently own a Systane iLux system identify new ways to aid patients and implement strategies for supporting the economic recovery of their practices. Visit SystaneiLux.com .
• Aldeyra Therapeutics, Inc. has announced an agreement with the FDA for the use of reactive aldehyde species (RASP) as an objective sign for dry eye disease (DED) treatment. RASP are pre-cytokine pro-inflammatory mediators elevated in the tears of DED patients and correlate with DED symptoms and signs. The company is working on a RASP inhibitor called reproxalap.
• Bausch + Lomb has announced it has received FDA 510(k) clearance for its INFUSE daily disposable silicone hydrogel contact lenses, which feature the lens material kalifilcon A.
• Blanchard Contact Lenses has launched onefitlenses.com , a new patient-facing website for the company’s Onefit family of scleral lenses. The site provides current or potential Onefit patients with an understanding of the design, features, benefits and indications for the Onefit family of scleral lenses, as well as care and handling resources, including application and removal videos. Also, prospective patients can find a Onefit fitter through the site’s interactive practitioner locator.
• CooperVision supported two ARVO studies with grants regarding myopia: (1) Retrospective Cohort Study of Safety of Pediatric Soft Contact Lens Wear and (2) a Population-Based Centile Analysis of Refractive Development. Both can be accessed from the ARVO Media library catalog within ARVOLearn.com . Additionally, the abstracts will be published in Investigative Ophthalmology & Visual Science next month.
• Dr. Contact Lens is an ecommerce service that enables practice owners to sell contact lenses via marketing tools, subscriptions/auto-ship options, direct shipping to patients and more. Learn more about the service or request a live demo at drcontactlens.com/doctors/ .
• Essilor has partnered with Luxottica on its Next GEN Offer by giving customers a $50 rebate when they combine qualifying premium Essilor lenses with a pair of branded frames from Luxottica’s portfolio. This offer for independent eye care practices will be available through Sept. 30, 2020. In other news, Essilor and the Essilor Vision Foundation have donated over 100,000 pieces of personal protective equipment to hospitals and first responders, optometry schools and Vision Source practices.
• Eye Designs LLC has launched four Office Disinfecting Packages through its new division, In Office Sterilization (inofficesterilization.com ). The packages include the Patented Electrostatic EPIX360 Sprayer technology, from EMist, and the eco-friendly medical grade hypochlorous acid Disinfectant + Sanitizer from Clean Republic.
• International Association of Contact Lens Educators (IACLE) has announced an online education program called “Teach. Learn. Connect.” to support educators, students and the industry, and help reduce the impact of the COVID-19 pandemic on global contact lens education. The program will supplement IACLE’s existing educational activities as the recovery from the COVID-19 pandemic continues. Visit iacle.org/the-tlc-teach-learn-connect-initiative/ .
• Johnson & Johnson Vision presented clinical research findings from its myopia clinical research program with the Singapore Eye Research Institute and Singapore National Eye Centre, as well as data on an antihistamine-releasing contact lens and multifocal and extended depth of focus designs, among other topics in eye care, during the virtual ARVO Annual Meeting. Visit ARVOLearn.com .
• Kala Pharmaceuticals, Inc. has announced that the FDA has accepted for review the company’s New Drug Application (NDA) resubmission for EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, its product candidate for the short-term treatment of dry eye disease signs and symptoms. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date of Oct. 30, 2020 for the completion of its review of the NDA.
• Optometry Giving Sight (OGS) has announced Anne Marie Hand, MPH, as its new executive director, North America. Eric Anderson, who served as the Interim executive director for the past year, will remain with OGS as the lead fundraiser.
• SynergEyes, Inc. has announced that UltraHealth hybrid lenses for keratoconus, as well as Duette lenses for regular corneas, may now be fit empirically. Learn more by visiting SynergEyes.com/professional . To design the Duette family of lenses, visit DuetteCalculator.com or call the technical consultation team.
• Tear Film & Ocular Surface Society (TFOS) board of directors has decided to cancel the TFOS 2020 Conference in Cernobbio, Italy (Sept. 9 to Sept. 12, 2020), due to the COVID-19 pandemic.
• Vision Expo. has announced that exhibit hall registration is now open for Vision Expo West (VEW) in Las Vegas, Sept. 23 to Sept. 26. Visit bit.ly/2YGuoDW for information. Registration for education sessions will open in July. Information on health and safety plans for the meeting can be found at bit.ly/2zJPmtg .
• X-Cel has launched the Choose Your Heroes program. Now through July 31, 2020, the company is giving practitioners the opportunity to honor the medical workers, first responders, police, fire fighters, teachers and military that walk through their practice doors, by giving them 50% off their specialty contact lenses that are manufactured and purchased direct from X-Cel.